Trial Outcomes & Findings for Comparing the Effectiveness of Two Therapies to Treat Signs of Anorexia Nervosa in Adolescents (NCT NCT00418977)

NCT ID: NCT00418977

Last Updated: 2015-12-23

Results Overview

Z-score was calculated using the Baylor College of Medicine Children's Nutrition Research Center's online BMI calculator

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

59 participants

Primary outcome timeframe

up to 1 year

Results posted on

2015-12-23

Participant Flow

Recruitment period Oct 2007 to Feb 2011 primarily via physicians and other clinicians/centers evaluating or treating children and adolescents with eating disorder symptoms.

Participant milestones

Participant milestones
Measure
Family Based Therapy
Participants received family based therapy (FBT) Family-Based Therapy ("Maudsley Method"): The goal of FBT is to resolve the eating disorder and return the patient to healthy psychosocial and physiological development through active family involvement across three treatment phases. In Phase I, therapy is focused on the disordered eating. The therapist primarily makes careful, persistent requests for united parental action toward re-feeding and/or regulating eating habits and directs the discussion so as to create and reinforce a strong parental alliance around their efforts at feeding their child. In Phase II, the goal is to gradually transfer control over eating back to the participant, with the parents still maintaining general oversight and responsibility for continued progression toward healthy habits. In Phase III, the central goal is establishment of a healthy child or adolescent relationship with the parents where disordered eating is not the basis of interaction.
Individual Supportive Psychotherapy
Participants received individual supportive psychotherapy (ISP) Individual Supportive Psychotherapy: The goal of ISP is for the patient to understand and address the psychological issues underlying the origin and maintenance of the eating disorder. This work is done directly with the child/adolescent. In this treatment, eating disorders are seen as complicated (e.g., they tend to mask other underlying difficulties). In Phase I, the aims are to establish a sound therapeutic relationship, obtain a comprehensive description of the eating problem and its development, identify underlying problems that might be responsible for the disordered eating, and inform the patient about the dangers of eating disorders. Phase II encourages participants to explore underlying emotional problems, facilitates self-disclosure and expression of feelings, and fosters independence. Phase III focuses on how other underlying issues might affect future adjustment.
Overall Study
STARTED
43
16
Overall Study
COMPLETED
40
13
Overall Study
NOT COMPLETED
3
3

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Comparing the Effectiveness of Two Therapies to Treat Signs of Anorexia Nervosa in Adolescents

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Family Based Therapy
n=43 Participants
Participants received family based therapy (FBT)
Individual Supportive Psychotherapy
n=16 Participants
Participants received individual supportive psychotherapy (ISP)
Total
n=59 Participants
Total of all reporting groups
Age, Continuous
13.3 years
STANDARD_DEVIATION 2.0 • n=5 Participants
14.8 years
STANDARD_DEVIATION 2.0 • n=7 Participants
13.7 years
STANDARD_DEVIATION 2.1 • n=5 Participants
Sex: Female, Male
Female
37 Participants
n=5 Participants
13 Participants
n=7 Participants
50 Participants
n=5 Participants
Sex: Female, Male
Male
6 Participants
n=5 Participants
3 Participants
n=7 Participants
9 Participants
n=5 Participants

PRIMARY outcome

Timeframe: up to 1 year

Z-score was calculated using the Baylor College of Medicine Children's Nutrition Research Center's online BMI calculator

Outcome measures

Outcome measures
Measure
Family Based Therapy
n=40 Participants
Participants received family based therapy (FBT)
Individual Supportive Psychotherapy
n=13 Participants
Participants received individual supportive psychotherapy (ISP)
Body Mass Index (BMI) Z-score
-0.72 z-score
Standard Deviation .99
-0.02 z-score
Standard Deviation .94

SECONDARY outcome

Timeframe: up to 1 year

This variable informs the calculation of the outcome variable of BMI Z-score.

Outcome measures

Outcome measures
Measure
Family Based Therapy
n=40 Participants
Participants received family based therapy (FBT)
Individual Supportive Psychotherapy
n=13 Participants
Participants received individual supportive psychotherapy (ISP)
Height
61.3 inches
Standard Deviation 4.7
63.6 inches
Standard Deviation 4.1

SECONDARY outcome

Timeframe: up to 1 year

This variable informs the calculation of the outcome variable of BMI Z-score.

Outcome measures

Outcome measures
Measure
Family Based Therapy
n=40 Participants
Participants received family based therapy (FBT)
Individual Supportive Psychotherapy
n=13 Participants
Participants received individual supportive psychotherapy (ISP)
Weight
94.9 pounds
Standard Deviation 21.0
114.7 pounds
Standard Deviation 29.1

SECONDARY outcome

Timeframe: up to 1 year

body mass index. This variable informs the calculation of the outcome variable of BMI Z-score.

Outcome measures

Outcome measures
Measure
Family Based Therapy
n=40 Participants
Participants received family based therapy (FBT)
Individual Supportive Psychotherapy
n=13 Participants
Participants received individual supportive psychotherapy (ISP)
BMI
17.6 kg/m^2
Standard Deviation 2.0
19.7 kg/m^2
Standard Deviation 3.0

SECONDARY outcome

Timeframe: up to 1 year

Body Mass Index (BMI) percentile. This is not a primary outcome variable.

Outcome measures

Outcome measures
Measure
Family Based Therapy
n=40 Participants
Participants received family based therapy (FBT)
Individual Supportive Psychotherapy
n=13 Participants
Participants received individual supportive psychotherapy (ISP)
BMI Percentile
30.1 percentile
Standard Deviation 22.5
42.1 percentile
Standard Deviation 29.4

Adverse Events

Family Based Therapy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Individual Supportive Psychotherapy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Katharine Loeb, PhD

Icahn School of Medicine at Mount Sinai

Phone: 212-659-8724

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place